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ABSTRACT
Oxidative stress activates macroautophagy/autophagy and contributes to atherogenesis via lipophagic ﬂux, a
form of lipid removal by autophagy. However, it is not known exactly how endogenous antioxidant enzymes
are involved in lipophagic ﬂux. Here, we demonstrate that the antioxidant PRDX1 (peroxiredoxin 1) has a
crucial role in the maintenance of lipophagic ﬂux in macrophages. PRDX1 is more highly expressed than
other antioxidant enzymes in monocytes and macrophages. We determined that Prdx1 deﬁciency induced
excessive oxidative stress and impaired maintenance of autophagic ﬂux in macrophages. Prdx1-deﬁcient
macrophages had higher intracellular cholesterol mass and lower cholesterol efﬂux compared with wild
type. This perturbation in cholesterol homeostasis was due to impaired lipophagic cholesterol hydrolysis
caused by excessive oxidative stress, resulting in the inhibition of free cholesterol formation and the
reduction of NR1H3 (nuclear receptor subfamily 1, group H, member 3) activity. Notably, impairment of both
lipophagic ﬂux and cholesterol efﬂux was restored by the 2-Cys PRDX-mimics ebselen and gliotoxin.
Consistent with this observation, apoe ¡/¡ mice transplanted with bone marrow from prdx1¡/¡apoe¡/¡ mice
had increased plaque formation compared with apoe¡/¡ BM-transplanted recipients. This study reveals that
PRDX1 is crucial to regulating lipophagic ﬂux and maintaining macrophage cholesterol homeostasis against
oxidative stress. We suggest that PRDX1-dependent control of oxidative stress may provide a strategy for
treating atherosclerosis and autophagy-related human diseases.
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Introduction
Autophagy is a catabolic pathway that uses the lysosomal appa-
ratus for degradation or recycling of cytoplasmic organelles
and aggregated proteins.1,2 Recent reports have revealed that
acquired defects in autophagy exacerbate atherosclerosis, which
suggests an anti-atherogenic function of autophagy.3,4 In par-
ticular, lipophagy, the autophagic removal of lipids, contributes
to macrophage cholesterol efﬂux and is closely linked to athero-
sclerosis.5 Autophagy is highly inducible and can be triggered
by environmental stressors, including oxidative stress caused
by reactive oxygen species (ROS).6 In addition to causing cell
damage and death, ROS mediate diverse cellular signaling path-
ways.7,8 As a secondary messenger, hydrogen peroxide (H2O2)
controls normal physiology and disease progression on the cel-
lular and organ levels in cancer, neurodegenerative diseases,
and cardiovascular diseases.9,10 Thus, oxidative stress induces
autophagy and concurrently regulates intracellular signaling by
reversibly oxidizing essential signaling components.11,12 To reg-
ulate the concentration of ROS, cells and tissues have developed
enzymatic systems including peroxiredoxins (PRDXs). How-
ever, whether an antioxidant enzyme can contribute to ROS
stress-induced autophagic ﬂux in the pathogenesis of athero-
sclerosis has not been studied yet.
PRDXs are a family of small, antioxidant proteins that con-
stitute a potent defense system for maintaining redox balance
by converting hydrogen peroxide to water.13 The 6 mammalian
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PRDXs (PRDX1 to PRDX6) are distributed in intracellular
compartments and are abundantly expressed.14 PRDX1 is
expressed in the cytosol of cells and was ﬁrst identiﬁed as a 23-
kDa stress-induced macrophage protein produced in murine
peritoneal macrophages exposed to oxidative stress.15,16 Prdx1-
deﬁcient mice show an increased frequency of multiple malig-
nant cancers.17 One report has suggested that laminar shear
stress induces PRDX1 upregulation in endothelial cells.18
Moreover, PRDX1 protects against chronic inﬂammation and
atherosclerosis by protecting against excessive endothelial acti-
vation.19 Our previous study demonstrates that Prdx2 deﬁ-
ciency exacerbates atherosclerosis by activation of cellular
adhesion molecules on the endothelial cells.20 In this study, we
conﬁrmed that Prdx1 is predominantly expressed and plays an
important role in monocytes/macrophages.
Macrophages play an essential role throughout the entire
pathogenesis of atherosclerosis.21 Macrophage foam cell forma-
tion caused by uncontrolled cholesterol efﬂux is a typical
marker of atherosclerosis. Recent studies have revealed that a
novel pathway involving autophagy regulation in macrophages
contributes to atherosclerosis.22,23 Therefore, we focused on
identifying the speciﬁc antioxidant enzyme responsible for
modulating autophagy as part of in vivo atherosclerotic signal-
ing pathways in macrophages. Here, we report that the ROS
scavenger PRDX1 is strongly expressed, in murine peritoneal
macrophages exposed to oxidative stress. We found that Prdx1
deﬁciency in macrophages led to increased susceptibility to oxi-
dative stress and suppressed the clearance of modiﬁed LDL as a
result of impaired lipophagic ﬂux, thereby promoting athero-
sclerosis in apoe¡/¡ mice. In addition, PRDX1 mimetics could
rescue the impaired lipophagic efﬂux induced by excessive oxi-
dative stress. Our data reveal a novel relationship of lipophagic
ﬂux and atherosclerosis by PRDX1 that controls the regulation
of H2O2 following lipid stimulation in macrophages.
Results
Prdx1 deﬁciency causes defective autophagic ﬂux
in macrophages
To investigate the role of antioxidant enzymes in the autopha-
gic pathways of macrophages, we ﬁrst compared the expression
levels of the genes encoding various antioxidant enzymes,
including Prdx1, Gpx1 (glutathione peroxidase 1), and Cat (cat-
alase), in primary peritoneal macrophages. At the mRNA level,
Prdx1 was more highly expressed than other antioxidant
enzymes in macrophages (Fig. 1A), and PRDX1 protein expres-
sion was higher in macrophages than in other cell types
involved in atherosclerosis, namely endothelial and smooth
muscle cells, or in whole tissues (Fig. 1B). Moreover, Prdx1 was
expressed at higher levels in myeloid cells than in other
immune cells (Fig. S1 with ImmGen database).24
To test the hypothesis that Prdx1 is crucial to the regulation
of oxidative stress in macrophages, we measured the intracellu-
lar H2O2 level in peritoneal macrophages from wild-type and
prdx1¡/¡ mice, both with or without oxidized LDL (oxLDL),
which mediates pro-inﬂammatory signals in atherosclerosis. As
expected, prdx1¡/¡ peritoneal macrophages had higher levels
of cellular H2O2 than did wild-type macrophages under both
basal and inﬂammatory conditions (as described in Fig. 1C
[CM-H2DCFDA] and Fig. S2 [Peroxy Orange 1]). To test
whether restoration of PRDX1 could ameliorate the H2O2 level,
we treated prdx1¡/¡ macrophages with either PRDX1-express-
ing (Ad-PRDX1) or control adenoviruses (Ad-control) and ver-
iﬁed the activity of Ad-PRDX1 in the prdx1¡/¡ macrophages
(Fig. S3). Treatment with Ad-PRDX1, but not Ad-control,
reduced the cellular H2O2 level in the prdx1
¡/¡ macrophages
under both basal and oxLDL-treated conditions. These results
indicate that PRDX1 is critically involved in the elimination of
H2O2 from pro-atherogenic macrophages (Fig. 1D).
To verify the effect of excessive H2O2 on autophagic ﬂux in
macrophages, autophagy pathways were monitored in Prdx1-
deﬁcient macrophages. Peritoneal macrophages were isolated
from 2 groups of mice carrying the gene for the green ﬂuores-
cent protein (GFP)- MAP1LC3B/LC3B (microtubule-associ-
ated protein 1 light chain 3 b), both with and without the
Prdx1 gene, and assayed for the puncta of GFP-LC3 during the
early stages of autophagy. Compared to the control, Prdx1-deﬁ-
cient macrophages displayed a more punctate pattern of ﬂuo-
rescence under both the glucose-starved and oxLDL-treated
conditions (Fig. 1E). Also, treatment with Ad-PRDX1 reduced
the puncta of GFP-LC3 in GFPtg-LC3 prdx1¡/¡ peritoneal mac-
rophages under oxLDL-treated conditions (Fig. 1F).
To analyze quantitative differences in autophagic ﬂux in
Prdx1 deﬁciency, we measured autophagy-related protein levels
in Prdx1-deﬁcient macrophages. SQSTM1/p62 (sequestosome
1), which shuttles intracellular protein aggregates into phago-
phores (the precursors to autophagosomes) for degradation, is
also a useful marker of autophagic status.25-27 Therefore, we
assessed levels of SQSTM1 in wild-type and prdx1¡/¡ murine
peritoneal macrophages that were incubated with or without
oxLDL. Surprisingly, SQSTM1 protein levels were signiﬁcantly
increased in Prdx1-deﬁcient macrophages under oxLDL-treated
conditions compared with wild-type macrophages (Fig. 1G).
Furthermore, treatment with Ad-PRDX1 rescued the level of
SQSTM1 protein in prdx1¡/¡ murine peritoneal macrophages
under oxLDL-treated conditions (Fig. 1H). The process of auto-
phagic ﬂux is inversely correlated with SQSTM1 level, such that
defective autophagic ﬂux is accompanied by accumulation of
SQSTM1 protein. To further verify that Prdx1 deﬁciency impairs
autophagic ﬂux, we used mCherry-GFP tandem ﬂuorescent-
tagged LC3 adenovirus.28,29 mCherryC GFPC-LC3 dots represent
autophagosomes or their precursors, whereas mCherryC GFP¡
dots indicate autolysosomes, because GFP ﬂuorescence is attenu-
ated by lysosomal acidic pH and hydrolases in autolysosomes.
In Prdx1-deﬁcient macrophages, the percentage of autolyso-
somes (mCherryC GFP¡-LC3 dots) to that of autophagosomes
(mCherryC GFPC-LC3 dots) obviously decreased (Fig. 1I), con-
ﬁrming that autophagic ﬂux was hampered by Prdx1 deﬁciency.
Collectively, these data provide evidence that Prdx1 deﬁciency
increases the production of excessive oxidative stress and impairs
the later stage of autophagic ﬂux in macrophages.
Prdx1 deﬁciency inhibits acidic cholesterol lipolysis
in macrophages
Lipophagy, a type of autophagy, is an important acidic choles-
terol hydrolysis pathway by which cytoplasmic lipid droplet
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(LD)-associated cholesteryl ester (CE) is delivered to lyso-
somes.5,30 Inhibition of cholesterol hydrolysis promotes exces-
sive CE accumulation in macrophages, thereby resulting in the
formation of foam cells. Therefore, we hypothesized that oxida-
tive stress resulting from Prdx1 deﬁciency can inhibit autopha-
gic cholesterol hydrolysis in macrophages. To test the
cholesterol efﬂux capacity of macrophages, we ﬁrst measured
the mass of both total cholesterol and CE in wild-type and
Prdx1-deﬁcient murine peritoneal macrophages. Lipid-loaded
macrophages were incubated with APOA1 in the presence of
modiﬁed LDL, and then an ACAT (acetyl-Coenzyme A acetyl-
transferase) inhibitor (ACATi) was added to prevent the re-
esteriﬁcation of hydrolyzed CE.31 We found signiﬁcant
increases in total cholesterol and CE mass in Prdx1-deﬁcient
Figure 1. Prdx1 deﬁciency causes defective autophagic ﬂux in macrophages. (A) Quantitative real-time PCR was performed to quantify mRNA levels of various antioxidant
enzymes in primary peritoneal macrophages from C57BL/6J mice (nD 10). Data are normalized to Actb expression. (B) Immunoblots probing for the PRDX1 to PRDX4 pro-
tein were performed on protein lysates from mouse aortic endothelial cells (MAEC), peritoneal macrophages (Mf), bone marrow-derived macrophages (BMDM), vascular
smooth muscle cells (VSMC), aortic tissue, and heart tissue from C57BL/6J mice (n D 5). Lysates (15 mg) and indicated amounts of recombinant PRDX1 were loaded onto
SDS-PAGE gels. (C) Fluorescence confocal microscopy images of CM-H2DCFDA-stained H2O2 expression in oxLDL-stimulated Mfs. Peritoneal Mfs were isolated from
Prdx1C/C and prdx1¡/¡mice (nD 3 per group), incubated with or without 50 mg/ml oxLDL for 30 min, and stained with CM-H2DCFDA. Quantitative data in the graph rep-
resent relative mean ﬂuorescence intensity (MFI). Scale bar: 100 mm. (D) Fluorescence confocal microscopy images of CM-H2DCFDA-stained H2O2 expression in oxLDL-
stimulated GFPtg-LC3 prdx1¡/¡ Mfs. GFPtg-LC3 prdx1¡/¡ Mfs were treated with PRDX1-expressing adenovirus (Ad-PRDX1) or control (Ad-con), incubated with or without
50 mg/ml oxLDL, and stained with CM-H2DCFDA (1mM). Scale bar: 10 mm. (E) Fluorescence confocal microscopy images of GFP-LC3. Mfs were isolated from mice of the
indicated genotype (n D 3 per group) and incubated with or without 50 mg/ml oxLDL for 30 min. Green ﬂuorescence indicates LC3 expression in Mf. Quantitative data
in the graph represent MFI. Scale bar: 10 mm. (F) Fluorescence confocal microscopy images of GFP-LC3 in GFPtg-LC3 prdx1¡/¡ Mf-treated Ad-PRDX1 or Ad-con. Scale bar:
10 mm. (G) Immunoblot analysis of autophagy proteins in Mf from Prdx1C/C or prdx1¡/¡ mice incubated with or without 50 mg/ml oxLDL. Quantitative data represent
the fold-change after normalizing protein band intensity to GAPDH. (H) Immunoblot analysis of autophagy proteins in prdx1¡/¡ Mf treated as in (F). Quantitative data
represent the fold change after normalizing protein band intensity to GAPDH. (I) Mf from Prdx1C/C or prdx1¡/¡ mice treated with Ad-mCherry-GFP-LC3. Cells were ﬁxed
and analyzed by immunoﬂuorescence microscopy. Scale bar: 5 mm. Quantitative data represent the percentages of (mCherryC GFP¡) dots/total (mCherryC GFPC) dots (n
> 20 cells from 3 independent experiments). , P < 0.01. Each experiment was performed 3 times, and all graphs are representative of 3 separate experiments. P <
0.05, P < 0.01, P < 0.001, by the Mann-Whitney test. Data represent the mean § SEM.
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macrophages relative to wild-type cells (Fig. 2A). Furthermore,
the ratio of cholesterol hydrolysis in Prdx1-deﬁcient macro-
phages was lower than in wild-type macrophages (Fig. 2B).
Next, we evaluated which CE hydrolysis pathway was sup-
pressed in Prdx1-deﬁcient macrophages using pathway-speciﬁc
pharmacological inhibitors. Paraoxon (which inhibits neutral
hydrolysis)32 led to an increase in CE mass in both wild-type
and Prdx1-deﬁcient macrophages, whereas chloroquine (which
inhibits acidic hydrolysis) increased the CE mass in wild-type,
but not in Prdx1-deﬁcient, macrophages (Fig. 2C). Collectively,
these results indicate that Prdx1-deﬁcient macrophages are
unable to hydrolyze cholesterol as efﬁciently as wild-type mac-
rophages due to impaired acidic CE hydrolysis.
NR1H3 (nuclear receptor subfamily 1, group H, member 3)
is an important regulator of cholesterol and fatty acid metabo-
lism in macrophages.33 Macrophage uptake of oxLDL leads to
increased cellular concentrations of oxysterols generated from
free cholesterol, the physiological ligand of NR1H3.34 Oxyster-
ols activate NR1H3-RXR (retinoid X receptor) heterodimers,
resulting in increased transcription of target genes,35 including
Figure 2. Prdx1 deﬁciency inhibits acidic cholesterol lipolysis in macrophages. (A) Following incubation with oxLDL (50 mg/ml) for 30 h, the levels of total cholesterol and
cholesteryl ester (CE) were measured in peritoneal Mfs using a cholesterol quantiﬁcation kit. Variations in cholesterol are expressed as fold change relative to the control.
(B) CE hydrolysis was calculated as follows: % hydrolysis D (CEi – CEf)/(CEi)100, where CEi represents the CE mass immediately after oxLDL loading, and CEf represents
the CE mass after the cells were incubated for 30 h. (C) Peritoneal Mfs were incubated with oxLDL for 30 h, and CE content was determined in the presence or absence
of the indicated reagents (100 mM paraoxon, 30 mM chloroquine). (D) Isolated peritoneal Mfs from the indicated mice were treated with oxLDL for 6 h. Nuclear and cyto-
plasmic extracts were prepared, and NR1H3 was detected by immunoblotting. Quantitative data of nuclear NR1H3 represent the fold change after normalizing protein
band intensity to LMNB (lamin B). (E) mRNA levels of Abca1 and Abcg1 in Prdx1C/C and prdx1¡/¡ murine peritoneal Mfs after treatment with modiﬁed LDL (50 mg/ml),
as determined by quantitative real-time PCR. (F) Isolated Mfs were incubated for 30 h in media containing modiﬁed LDL (50 mg/mL) with 3H-cholesterol (5 mCi/mL), and
cholesterol efﬂux was determined in the presence of human recombinant APOA1 (10 mg/mL) or mouse serum (2%) for 6 h. Efﬂux is expressed as a percentage of 3H-cho-
lesterol in medium to 3H-cholesterol in mediumC3H-cholesterol in cells. P < 0.05, P < 0.01, and P < 0.001, by the Mann-Whitney test. All experiments were per-
formed 3 times, and all graphs are representative of 3 separate experiments (A, B, C and D, n D 15 per group; E and F, n D 10 per group). Data represent the mean §
SEM.
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those encoding APOE, ABCA1 [ATP-binding cassette, sub-
family G [ABC1], member 1), and ABCG1 (ATP-binding cas-
sette, sub-family G [WHITE], member 1). Therefore, we exam-
ined the activation of NR1H3 and its target genes in wild-type
and Prdx1-deﬁcient macrophages. Nuclear NR1H3 was
increased with oxLDL in wild-type control macrophages. How-
ever, the nuclear translocation of NR1H3 was reduced in both
the basal and oxLDL-treated Prdx1-deﬁcient macrophages
(Fig. 2D). Furthermore, we observed signiﬁcantly lower mRNA
expression of Nr1h3 targets, such as Abca1 and Abcg1, in
Prdx1-deﬁcient macrophages than in wild-type macrophages
after treatment with modiﬁed LDL (Fig. 2E). ABC transporters
have recently been reported to play a role in regulating the
efﬂux of cellular cholesterol and phospholipids to speciﬁc lipid
acceptors (e.g., HDL or APOA1) in the media.36,37 We next
analyzed the cholesterol efﬂux from wild-type and prdx1¡/¡
macrophages preloaded with [3H]-cholesterol using APOA1 or
mouse serum as a carrier. Cholesterol efﬂux was signiﬁcantly
reduced in macrophages from prdx1¡/¡ mice using both car-
riers (Fig. 2F). These results suggest that PRDX1 plays a pivotal
role in cholesterol efﬂux in macrophages.
2-Cys PRDX-mimics rescue impaired lipophagic ﬂux and
cholesterol efﬂux in macrophages
The antioxidant ebselen (Eb) and the immunosuppressive myco-
toxin gliotoxin (Gt) are both capable of counteracting hydrogen
peroxide by mimicking antioxidant protein activity.38,39 We used
these synthetic antioxidants to ascertain whether normalizing
the endogenous H2O2 level could rescue impaired lipophagy in
Prdx1-deﬁcient macrophages. Measurement of intracellular
H2O2 level (Fig. 3A) and GFP-LC3 ﬂuorescence analysis revealed
that Eb and Gt potently reduced H2O2 level and decreased the
puncta number of GFP-LC3 and the subsequent activation of
Figure 3. 2-Cys PRDX-mimics rescue impaired lipophagic ﬂux and cholesterol efﬂux in macrophages. (A) Fluorescence confocal microscopy images of CM-H2DCFDA-
stained H2O2 expression in oxLDL-stimulated Mfs. Peritoneal Mfs were isolated from Prdx1
C/C and prdx1¡/¡ mice, pretreated with 10 mM ebselen (Eb) or 20 nM glio-
toxin (Gt) for 1 h, incubated with or without 50 mg/ml oxLDL for 30 min, and stained with 5 mM CM-H2DCFDA (nD 3 per group). Quantitative data in the graph represent
relative mean ﬂuorescence intensity (MFI). Scale bar: 10 mm. (B) Mfs were isolated from mice of the indicated genotype (n D 3 per group) and treated as in (A). Green
ﬂuorescence indicates LC3 expression in Mfs. Quantitative data in the graph represent MFI. Scale bar: 10 mm. (C) Immunoblot analysis of SQSTM1 in Mfs from Prdx1C/C
or prdx1¡/¡ mice, treated as in (A). Quantitative data represent the fold change after normalizing SQSTM1 band intensity to GAPDH. (D) Cholesterol efﬂux was measured
in macrophages that were incubated in media containing oxLDL with 3H-cholesterol (5 mCi/mL) for 30 h and then pretreated with Eb (10 mM) or Gt (20 nM) for 1 h in the
presence of APOA1 (10 mg/mL). P< 0.05, P< 0.01, and P< 0.001, by the Mann-Whitney test. Each experiment was performed 3 times, and all graphs are represen-
tative of 3 separate experiments. Data represent the mean § SEM.
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GFP-LC3 ﬂuorescence in Prdx1-deﬁcient macrophages induced
by oxLDL (Fig. 3B). Furthermore, immunoblot analysis revealed
that Eb and Gt also suppressed SQSTM1 accumulation in
oxLDL-treated Prdx1-deﬁcient macrophages (Fig. 3C). Impor-
tantly, incubation of macrophages with Eb and Gt effectively
recovered cholesterol efﬂux in prdx1¡/¡ macrophages (Fig. 3D).
Collectively, these results conﬁrm that the impaired lipophagic
ﬂux in Prdx1-deﬁcient macrophages is associated with the
increase in oxidative stress.
Prdx1 deﬁciency increases macrophage foam cells
in atherosclerotic plaques
To elucidate whether the impaired lipophagic ﬂux caused by
oxidative stress in Prdx1-deﬁcient macrophages affects macro-
phage function, we ﬁrst examined the lipoprotein uptake abil-
ity of macrophages. Peritoneal macrophages were isolated
from wild-type and prdx1¡/¡ mice, incubated with oxLDL,
and then stained with Oil Red O solution. We found that
Prdx1-deﬁcient macrophages uptake more oxLDL and
increase storage of neutral lipids within the cell compared
with wild-type macrophages (Fig. 4A). Therefore, we decided
to examine whether Prdx1 deﬁciency affects foam cell forma-
tion using macrophages isolated from atherosclerotic plaques.
First, apoe¡/¡ and prdx1¡/¡apoe¡/¡ mice were fed a high-fat
diet for 10 wk, and then their aortas were isolated and dissoci-
ated with an enzyme mixture. Next, aortic cells were
incubated with BODIPY (a commonly used ﬂuorescent neu-
tral-lipid dye) and stained with various immune cell-speciﬁc
antibodies to identify macrophage foam cells. Flow cytometry
analysis showed that aortic macrophage foam cell number and
percentage were higher in prdx1¡/¡apoe¡/¡ mice than in
apoe¡/¡ mice (Fig. 4B). These results indicate that Prdx1-
deﬁciency contributes to macrophage foam cell formation.
Figure 4. Prdx1 deﬁciency increases foam cell formation. (A) Comparison of in vitro foam cells from peritoneal Mfs from Prdx1C/C and prdx1¡/¡ mice in response to
50 mg/ml oxLDL (n D 3 per group). Mfs were stained with Oil Red O solution, and the percentage of foam cells was calculated in total cells in the ﬁeld. Scale bar: 50 mm.
(B) Flow cytometry of foam cells isolated from whole aortas (from the aortic sinus to the femoral aorta) from apoe¡/¡ and prdx1¡/¡apoe¡/¡ mice fed an atherogenic diet
for 10 wk (n D 5 per group). Aortic macrophages were isolated from apoe¡/¡ and prdx1¡/¡apoe¡/¡ mice following incubation with 10 mg/ml BODIPY. Staining with an
isotype control Ab is shown (gray histogram). Quantitative data represent percentage of BODIPYC macrophages per PTPRC/CD45C cells. P < 0.05, P < 0.001, by the
Mann-Whitney test. Each experiment was performed 3 times, and all graphs are representative of 3 separate experiments. Data represent the mean § SEM.
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Prdx1 deﬁciency induces lipophagy dysfunction
in atherosclerotic plaques
Expanding on previous observations,19 atherosclerotic plaque
formation was increased in prdx1¡/¡apoe¡/¡ mice compared
with their apoe¡/¡ counterparts when fed either a high-fat diet
(Fig. S4A and S4B) or a normal chow diet (Fig. S4C and S4D).
Also, immunoﬂuorescent staining showed a signiﬁcant increase
in macrophage inﬁltration in prdx1¡/¡apoe¡/¡ mice compared
with apoe¡/¡mice (Fig. S4E).
To assess the efﬁcacy of the lipophagic process, we analyzed
the lipids within lipophagic vacuoles in atherosclerotic aortic
macrophages from apoe¡/¡ mice and prdx1¡/¡apoe¡/¡ mice
using electron microscopy. Micrographs of atherosclerotic aortas
from prdx1¡/¡apoe¡/¡ mice showed an increased size of lipid-
containing vesicles (LD) and the destruction of macrophage
foam cells (red triangle) (Fig. 5A). Additionally, lipophagic
vacuoles surrounded by double membranes were more abundant
in these samples than in those from apoe¡/¡ mice. Furthermore,
atherosclerotic aortas from prdx1¡/¡apoe¡/¡ mice had the char-
acteristic residual material of a lysosomal degradation product,
which consists of a double-membrane vesicle containing par-
tially undegraded intracellular material (Fig. 5A, red circle). To
monitor in vivo lipophagic ﬂux in Prdx1 deﬁciency, we mea-
sured autophagy-related protein levels in atherosclerotic plaques
from aortas of apoe¡/¡ or prdx1¡/¡apoe¡/¡ mice fed a high-fat
diet. The atherosclerotic aortic lysates from prdx1¡/¡apoe¡/¡
mice showed higher expression of LC3-II than those from
apoe¡/¡ mice (Fig. 5B). Also, we assessed the SQSTM1 level in
aortic lysates from apoe¡/¡ or prdx1¡/¡apoe¡/¡ mice on an ath-
erogenic diet. The SQSTM1 protein level was dramatically
increased in aortas from prdx1¡/¡apoe¡/¡ mice compared with
apoe¡/¡ mice (Fig. 5C). In contrast, the expression levels of
Sqstm1 mRNA were the same between the 2 groups of mice
(Fig. 5D). These results indicate that Prdx1 deﬁciency induces
SQSTM1 accumulation through defective lipophagic ﬂux in ath-
erosclerotic plaque.
Lipid accumulation is a hallmark of atherosclerotic pla-
ques,40 and persistently undissolved LDs lead to lipophagy dys-
function in macrophages, causing the lipid to remain trapped
in the lysosomal compartment. We used BODIPY to measure
the neutral lipid stored area in atherosclerotic plaques from the
aortic sinus of apoe¡/¡ or prdx1¡/¡apoe¡/¡ mice fed a high-fat
diet. In addition to increased plaque formation, neutral lipid
area (as determined by microscopy) was increased in the ath-
erosclerotic plaques of prdx1¡/¡apoe¡/¡ mice (Fig. 5E). Alto-
gether, these observations suggest that lipid turnover is
decreased in Prdx1-deﬁcient macrophages within plaques, and
that excessive oxidative stress disturbs lipophagic ﬂux in an ath-
erogenic state.
Impaired lipophagic ﬂux in Prdx1-deﬁcient hematopoietic
cells exacerbates plaque formation in apoe¡/¡mice
To assess the contribution of lipophagic ﬂux impairment in
Prdx1-deﬁcient macrophages to the atherosclerotic pathology
of these mice, we transferred bone marrow (BM) cells obtained
from apoe¡/¡ or prdx1¡/¡apoe¡/¡ mice into lethally-irradiated
apoe¡/¡ or prdx1¡/¡apoe¡/¡ recipient mice. Four wk after
transplantation, the mice were fed a high-fat diet for 10 wk.
hematoxylin and eosin staining showed that apoe¡/¡ mice
transplanted with BM cells from prdx1¡/¡apoe¡/¡mice formed
signiﬁcantly more atherosclerotic plaques than did apoe¡/¡
BM-transplanted apoe¡/¡ mice (Fig. S5). The same trend was
observed in BM-reconstituted prdx1¡/¡apoe¡/¡ mice. Consis-
tent with the increased plaque area, neutral lipid content (as
assessed by Oil Red O staining) was also increased in BM cells
of prdx1¡/¡apoe¡/¡ transplanted apoe¡/¡ mice compared with
apoe¡/¡ BM-transplanted apoe¡/¡ mice (Fig. 6A and B). Fur-
thermore, the plaques of apoe¡/¡ mice transplanted with
Prdx1-deﬁcient BM cells (prdx1¡/¡apoe¡/¡ or GFPtg-LC3
prdx1¡/¡apoe¡/¡) had greater numbers of lesional macro-
phages (Fig. 6C) and LC3 colocalized macrophages (Fig. 6D)
than those transplanted with BM cells from apoe¡/¡ or GFPtg-
LC3 apoe¡/¡ mice. Finally, the level of SQSTM1 protein was
dramatically increased in aortas from apoe¡/¡ mice trans-
planted with BM cells from prdx1¡/¡apoe¡/¡ mice compared
with apoe¡/¡ BM-transplanted apoe¡/¡ mice (Fig. 6E). In con-
clusion, these data show that deﬁciency of Prdx1 in hematopoi-
etic cells, but not in vascular tissues, is sufﬁcient to accelerate
lipophagic impairment and atherosclerotic plaque formation.
Discussion
This study demonstrates that the underlying mechanism of
excessive oxidative stress in Prdx1-deﬁcient macrophages is
increased foam cell formation caused by impaired lipophagy.
Furthermore, our study conﬁrms that lipophagy is important
for the control of atherosclerosis in vivo. The links between lip-
ophagic ﬂux, oxidative stress, and atherogenesis are summa-
rized in Fig. 7.
Prdx1 deﬁciency causes an increase of H2O2 ROS in macro-
phages. H2O2 ROS causes cellular stress and activates apoptosis,
the elimination of which are presumably better for cells. Conse-
quently, an incremental increase of H2O2 ROS within cells
induces autophagy activation for cell survival.41 To date, how-
ever, the autophagic ﬂux in response to H2O2 ROS remains
largely elusive and poorly understood. Herein, we demonstrate
that Prdx1-deﬁcient macrophages exposed to oxLDL undergo a
lipophagic ﬂux impairment characterized by accumulation of
SQSTM1, which has been reported as a known marker of defec-
tive autophagy.42 Furthermore, we show that an increase of CE
accumulation correlates with an inhibition of acidic lipolysis in
normal macrophages, whereas Prdx1-deﬁcient macrophages
did not change their CE mass under conditions of chloroquine
treatment. Thus, the data presented here suggest that oxidative
stress caused by Prdx1 deﬁciency results in the accumulation of
CE within macrophages and foam cell formation, and suggest
that PRDX1 and H2O2 ROS could be actively involved in the
regulation of lipophagic ﬂux by participating in autolysosome
formation.
Some autophagy components have a characteristic hydro-
phobicity, which plays a role in forming the autophagosome.
For example, LC3-II has stronger hydrophobicity than LC3-I,
because LC3-II is combined with the phosphatidylethanol-
amine group.43 Furthermore SQSTM1, Atg19 and Atg32 have a
speciﬁc motif for binding to the conserved hydrophobic pock-
ets on LC3/Atg8.44 Although the hydrophobic nature of these
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Figure 5. Prdx1 deﬁciency induces lipophagy dysfunction in atherosclerotic plaques. (A) Electron microscopy showing the number and size of cytoplasmic lipid droplets
(LD) and residual bodies (red circle) in apoe¡/¡ and prdx1¡/¡apoe¡/¡ mice (n D 3 per group). Quantitative data (below) represent the relative LD size. Scale bar: 2 mm.
Immunoblot analyses of LC3B (B) and SQSTM1 (C) expression in extracts from the aortas of apoe¡/¡ and prdx1¡/¡apoe¡/¡ mice fed an atherogenic diet for 10 wk. GAPDH
was used as a loading control. Quantitative data represent the fold change after normalizing LC3B-II:LC3B-I and SQSTM1 band intensity to GAPDH. (D) mRNA levels of
Sqstm1 in the aortas of apoe¡/¡ and prdx1¡/¡apoe¡/¡ mice as determined by quantitative real-time PCR (B, C and D, n D 5 per group). (E) Confocal microscopy images
of BODIPY-stained aortic sinuses from apoe¡/¡ and prdx1¡/¡apoe¡/¡ mice fed an atherogenic diet for 10 wk (n D 8–12 per group). Quantitative data represent relative
mean ﬂuorescence intensity (MFI). Scale bar: 100 mm. P < 0.05, P < 0.001, by the Mann-Whitney test. Data represent the mean § SEM.
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components can be changed to hydrophilic and water-soluble
by oxidation in the presence of the H2O2 ROS,
45 the mecha-
nisms by which PRDX1 is involved in the autophagic ﬂux dys-
function still remain unclear. Therefore, considering the
complex roles of oxidative stress in the regulation of autophagy,
it would be important to further elucidate the key step that is
impaired by the Prdx1 deﬁciency-induced oxidative stress with
regard to lipophagic ﬂux.
Lipophagy, the selective lipophagic degradation of LDs, has
been observed in various cell types.6,46,47,48 Additionally, recent
studies have shown that impaired lipophagy can exacerbate
atherosclerosis.49 Lipophagic regulation of cholesterol homeo-
stasis is a new concept that has important implications for car-
diovascular disease.50 Although several studies have used cell
type-speciﬁc knockouts or heterozygosity of autophagy-related
(Atg) genes, autophagy-deﬁcient states in mice are expected to
have disparate phenotypes from cellular autophagic processes
in normal states. That is, previous studies did not consider the
autophagic ﬂux in the steady state. In contrast, our study shows
that the lipophagic process during atherosclerosis appears to be
independent of any Atg deﬁciency and indicates that oxidative
stress suppresses lipophagic ﬂux in response to modiﬁed LDL.
We found that speciﬁcally lipophagy is induced in response to
atherogenic lipoprotein loading; thus, the acidic lipophagic
pathway for CE hydrolysis in LDL is the one that clearly is trig-
gered by oxidative stress. Our observation supports the previ-
ously veriﬁed role of autophagy in cholesterol efﬂux, a process
that that also involves activation of NR1H3 and its downstream
Figure 6. Impaired lipophagic ﬂux in Prdx1-deﬁcient haematopoietic cells exacerbates plaque formation in apoe¡/¡ mice. Bone marrow (BM) from apoe¡/¡ or prdx1¡/
¡apoe¡/¡ mice was transplanted into apoe¡/¡ or prdx1¡/¡apoe¡/¡ recipients. Four weeks after transplantation, mice were fed an atherogenic diet for 10 wk. Representa-
tive images of Oil Red O staining of aortas (A) and aortic sinuses (B) from apoe¡/¡ and prdx1¡/¡ apoe¡/¡ recipient mice transplanted with apoe¡/¡ or prdx1¡/¡apoe¡/¡
BM (n D 11–16 per group). Quantitative data represent plaque percentage (%) or size. (C) Representative immunostaining images of the macrophage marker CD68 in
apoe ¡/¡ recipient mice transplanted with BM from apoe¡/¡ or prdx1¡/¡apoe¡/¡ donors (n D 10 per group). CD68 is shown in red and nuclei in blue. Scale bars:
100 mm. Quantitative data in the graph represent the percentage of the total plaque area that was positively stained. (D) Representative confocal microscopy images of
plaques from apoe¡/¡ mice transplanted with BM cells from GFPtg-LC3 apoe¡/¡ or GFPtg-LC3 prdx1¡/¡apoe¡/¡ mice (n D 3 per group). LC3 is shown in green, macro-
phages in red, and nuclei in blue. Scale bar: 10 mm. (E) Immunoblot analysis of SQSTM1 expression in extracts from the aortas of apoe ¡/¡ recipient mice transplanted
with BM from apoe¡/¡ or prdx1¡/¡apoe¡/¡ donors. Quantitative data represent the fold change after normalizing LC3B-II, LC3B-I and SQSTM1 band intensity to GAPDH.
P < 0.05 and P < 0.01 versus apoe ¡/¡ recipient mice transplanted with apoe¡/¡ BM; #P < 0.05 versus prdx1¡/¡apoe¡/¡ recipient mice transplanted with apoe¡/¡
BM, by the Mann-Whitney test. Data represent the mean § SEM.
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target ABCA1.35,51 A recent report showed that autophagy-
mediated efﬂux is closely linked to ABCA1 and is involved
with NR1H3, limiting the expression of ABCA1 in autophagy-
defective conditions.5 Moreover, it was not possible to rescue
cholesterol efﬂux in Lalistat 1-treated and Atg5-deﬁcient mac-
rophages using an NR1H3 activator (T0901317). Prdx1-deﬁ-
cient macrophages fail to activate the Nr1h3 nuclear expression
in response to reducing of free cholesterol under these lipopha-
gic ﬂux-limiting conditions. Thus, these results suggest that
increased oxidative stress in the absence of PRDX1 expression
reduced cholesterol efﬂux in macrophages, a process that
seemed to be dependent on NR1H3 activation.
Accumulating evidence demonstrates that autophagy plays
an important role in inhibiting inﬂammation and apoptosis,
and in promoting efferocytosis and cholesterol efﬂux. These
results suggest the defect in autophagy can inﬂuence the pro-
gression of several chronic diseases, such as atherosclerosis. In
this study, we show for the ﬁrst time that PRDX1 is the most
effective antioxidant enzyme, which maintains the in vivo lipo-
phagic ﬂux against inducible oxidative stress within atheroscle-
rotic macrophages. PRDX1 was ﬁrst discovered as a 23-kDa
stress protein in macrophages,15 and we showed that macro-
phages had the highest level of PRDX1 expression of all cells
occurring in atherosclerotic plaques. Prdx1 deﬁciency can lead
to dysfunctional lipophagy, accumulation of SQSTM1 and
increased atherosclerotic plaques in Apoe-deﬁcient mice. Fur-
thermore, bone marrow transplantation experiments demon-
strated that PRDX1 is expressed in hematopoietic cells to
protect susceptible Apoe-deﬁcient mice from atherosclerosis.
We did not observe a signiﬁcant increase in atherosclerotic
pathology in mice that had Prdx1 deﬁciency in only nonhema-
topoietic cells. Therefore, the increased levels of endothelial
SELP/P-selectin, soluble SELP, and VWF (Von Willebrand fac-
tor) previously found in the plasma of Prdx1-deﬁcient mice
could be an effect of the inﬂammatory state caused by whole
body Prdx1-deﬁciency.19
To block intracellular H2O2 in an attempt to recover
impaired lipophagy, we used the synthetic antioxidants ebselen
and gliotoxin, which are effective at scavenging intracellular
H2O2 in vitro and in vivo through 2-Cys PRDX-like
mechanisms. The results of this study showed for the ﬁrst time
that ebselen and gliotoxin effectively rescue the impairment of
autophagy that is associated with Prdx1 deﬁciency, which indi-
cates that oxidative stress may inﬂuence cholesterol efﬂux in
macrophages by regulating lipophagy. Collectively, understand-
ing the interactions between antioxidant mimics and lipophagy
should be considered in atherosclerosis to explore the effects of
oxidative stress and autophagy-related disease.
In conclusion, the data presented here show that PRDX1 is
essential in maintaining lipophagic ﬂux and cholesterol homeo-
stasis. Our results shed light on the undiscovered links between
lipophagic ﬂux, oxidative stress, and the antioxidant PRDX1 in
macrophages. Additionally, these results also suggest that 2-
Cys PRDX-mimics, such as ebselen and gliotoxin, might be
useful for treating atherosclerosis and defective lipophagy-
related diseases.
Materials and methods
Experimental animals
To generate prdx1¡/¡apoe¡/¡ mice, GFPtg-LC3 prdx1¡/¡ mice,
and GFPtg-LC3 prdx1¡/¡apoe¡/¡ mice, prdx1¡/¡ mice were
crossed with either apoe¡/¡ mice or GFPtg-LC3 mice.52 All
prdx1¡/¡apoe¡/¡, GFPtg-LC3 prdx1¡/¡, and GFPtg-LC3
prdx1¡/¡apoe¡/¡strains were C57BL/6J congenic lines back-
crossed more than 10 times with C57BL/6J mice. We used
male mice for all experiments. Mice were housed in a speciﬁc
pathogen-free system, maintained on a 12-h light/dark cycle,
and kept at 22–23C with water ad libitum. All animal study
protocols were approved by the Institutional Animal Care and
Usage Committee (IACUC No. 2012–01–052) of Ewha Wom-
ans University.
Primary peritoneal macrophage culture
Peritoneal macrophages were obtained from the peritoneal cav-
ity at 3 d after mice were injected with 4% thioglycollate broth
(Fluka, 70157).3,23,30 The cells obtained were washed with phos-
phate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl,
Figure 7. Model for the function of Prdx1 in the lipophagic ﬂux of macrophages. PRDX1 is the most highly expressed antioxidant enzyme in macrophages, and it is highly
effective at eliminating H2O2 in monocytes and macrophages. Prdx1 deﬁciency in macrophages inhibits lipophagic ﬂux and reduces acidic cholesterol hydrolysis. Overall,
PRDX1 maintains lipophagic ﬂux by scavenging ROS H2O2 in monocytes and macrophages. HDL, high-density lipoprotein; VLDL, very low-density lipoprotein.
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10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4), centrifuged at
400 g for 5 min, and suspended in Dulbecco’s modiﬁed Eagle’s
medium (DMEM; Hyclone, SH30243.01) containing 10% heat-
inactivated fetal bovine serum (Hyclone, SH30919.03),
100 units/ml penicillin (Gibco, 15140–122), and 2 mM L-gluta-
mine (Gibco, 25030–081). Cells were cultured at 37C under a
5% CO2 atmosphere. Two h later, non-adherent cells were
removed by washing with PBS, and adherent macrophages
were used for subsequent experiments.
Cellular hydrogen peroxide staining
Isolated peritoneal macrophages were plated on a confocal dish
(SPL Life Sciences, 20350) and stimulated with 50 mg/ml
oxLDL (Alfa Aesar, J65591) for 30 min. Next, cells were washed
with Hank’s balanced salt solution (WelGENE, LB003–02),
incubated with 10 mM CM-H2DCFDA (Molecular Probes,
C6827) in DMEM for 30 min, and imaged. For experiments
with the H2O2-speciﬁc probe Peroxy Orange 1 (PO1; Tocris
Bioscience, 4944), peritoneal macrophages were incubated with
5 mM PO1 for 40 min at 37C, mixed with 50 mg/ml oxLDL
for 20 min, and then imaged. The cells were then kept in an
incubator (37C, 5% CO2) during the course of all experiments
and imaged by confocal microscopy (Carl Zeiss, Jena,
Germany; LSM 780).
Adenovirus transduction and ﬂuorescence microscopy
For PRDX1-expressing adenovirus transduction, peritoneal
macrophages were plated on a confocal dish, incubated with
Ad-Con or Ad-PRDX1 (2 £ 109 plaque-forming units [pfu])
for 24 h, stimulated by oxLDL and then imaged with an LSM
780 confocal microscope. For Ad-mCherry-GFP-LC3 transduc-
tion, peritoneal macrophages were plated on coverslips, incu-
bated with Ad-mCherry-GFP-LC3 (2 £ 109 pfu) for 24 h, and
then stimulated with oxLDL. Cells were ﬁxed with 4% parafor-
maldehyde in PBS at 4C, coverslips were mounted onto slides
using mounting medium for ﬂuorescence with DAPI (Thermo
Fisher Scientiﬁc, H-1200) and imaged with an LSM 780 confo-
cal microscope. Percentages of colocalization are shown as
(mCherryC GFP¡) dots/total (mCherryC GFPC) dots quanti-
ﬁed by the imageJ program.27
Aortic single-cell preparation and ﬂow cytometry analysis
Aortic single cells were prepared using described previously
methods.53 Brieﬂy, after careful removal of perivascular fat
using microscissors under a dissecting microscope, single-cell
suspensions from whole aortic segments were prepared by
incubation with an enzyme mixture containing 675 U/ml colla-
genase I (C0130), 187.5 U/ml collagenase XI (C7657), 90 U/ml
hyaluronidase (H3884), and 90 U/ml DNase (DN25) (all
obtained from Sigma Aldrich) in Hank’s balanced salt solution
with calcium and magnesium for 90 min at 37C with gentle
shaking. To analyze surface markers on macrophages, cell sus-
pensions from the aortas of mice were incubated with perCP
anti-mouse PTPRC/CD45 (BioLegend, 103129), brilliant violet
605 anti-mouse ADGRE1/F4/80 (BioLegend, 123133), APC/
Cy7 anti-mouse MHC class II (I-A/I-E) (BioLegend, 107627),
APC anti-mouse/human ITGAM/CD11b (BioLegend, 101211),
PE anti-mouse FCGR1/CD64/FCgRI (BioLegend, 139303) and
BODIPY (Molecular Probes, D3922). We used a FACS BD
LSRFORTESSA ﬂow cytometer and analyzed the data with Cell
Quest Pro software (BD Biosciences).
Immunohistochemistry and ﬂuorescence microscopy
For staining of macrophages within atherosclerotic plaques,
BODIPY and rat anti-CD68 (AbD Serotec, MCA1957) primary
antibodies were used. After incubation with primary antibodies,
Alexa Fluor 594-labeled anti-rat secondary antibodies (Invitro-
gen, A21471) were used to visualize the antigens. DAPI was
used to label the nuclei (Sigma Aldrich, D9542). Negative con-
trol tissues were prepared in a similar manner using rat IgG iso-
type control antibodies (Santa Cruz Biotechnology, sc-2026).
Samples were analyzed using an LSM Image Examiner (Carl
Zeiss, Jena, Germany; LSM780).
Cellular lipid staining
For ex vivo assessment of macrophage cholesterol accumula-
tion, peritoneal macrophages were isolated from Prdx1C/C and
prdx1¡/¡ mice, plated, and stimulated with 50 mg/ml oxLDL
for 48 h. Cells were stained with Oil Red O solution (Sigma
Aldrich, O0625) for 1 h and then brieﬂy washed with PBS.
Macrophages with more than 10 lipid droplets were deﬁned as
foam cells and the percentage of foam cells was calculated in
the total cell ﬁeld.
Quantitative real-time PCR analysis
Total RNA was isolated using Isol-RNA Lysis reagent (5
PRIME, 2302700), suspended in diethylpyrocarbonate (Sigma
Aldrich, D5758)-treated water, and stored at ¡80C. cDNA
was synthesized with the RevertAid ﬁrst strand cDNA synthesis
kit (Thermo Fisher Scientiﬁc, K1622). Quantitative real-time
PCR was performed using the KAPA SYBR FAST Master Mix
(Kapa Biosystems, KK4602) with a 7700 sequence detector
(Applied Biosystems). Calculations were performed using a
comparative method (2¡CT) with Actb as the internal control.
The primers are listed in Table S1.
Immunoblot analysis
To isolate proteins, samples were lysed in RIPA buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% SDS (Sigma Aldrich,
L3771), 1% NP-40 (Sigma Aldrich, NP-40S), 0.25% sodium
deoxycholate (Sigma Aldrich, D6750), 1 mM EDTA, 1 mM
sodium ﬂuoride, 1 mM Na3VO4) with a protease inhibitor
cocktail (Roche Life Science, 11 697 498 001). For immunoblot
analysis, proteins were electrophoresed on SDS-polyacrylamide
gels and transferred onto PVDF membranes. The membranes
were blocked with 4% skim milk (BD Difco, 232100) in Tris-
buffered saline (TBS; 50 mM Tris-Cl, 150 mM NaCl, pH 7.5)
containing 0.5% Tween-20 (Sigma Aldrich, P1379; TBST) and
subsequently incubated with anti-PRDX1 (Abcam, ab41906),
anti-PRDX2 (AbFrontier, LF-PA0007), anti-PRDX3 (AbFront-
ier, LF-PA0030), anti-PRDX4 (AbFrontier, LF-PA0009),
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anti-NR1H3/LXRa (Abcam, ab41902), anti-LC3B (Cell Signal-
ing Technology, 2775), anti-SQSTM1/p62 (Abcam, ab56416),
anti-CD36 (Santa Cruz Biotechnology, sc-9154), anti-LMNB/
laminB (Santa Cruz Biotechnology, sc-6217) and anti-GAPDH
(Santa Cruz Biothechnology, sc-25778) primary antibody and
horseradish peroxidase-conjugated secondary antibody (Milli-
pore, AP106P, AP124P and AP124P). Immunoreactive bands
were detected with ECLTM western blotting reagents (GE
Healthcare Life Sciences, RPN2106).
Cellular cholesterol measurement
The Cholesterol Quantitation Kit (BioVision, K603–100) was
used to determine the cellular masses of cholesterol and choles-
teryl ester (CE). Peritoneal macrophages from Prdx1C/C and
prdx1¡/¡ mice were incubated for 30 h in medium containing
50 mg/mL of modiﬁed lipoproteins and 10 mg/mL ACATi
(Sandoz, 58–035; Sigma Aldrich, S9318). Variations in CE are
expressed as percent hydrolysis or as fold change relative to the
control, and CE hydrolysis was calculated as follows: % hydro-
lysis D (CEi – CEf)/(CEi)100, where CEi represents the CE
mass immediately after oxLDL loading, and CEf represents the
CE mass after the cells were incubated for 30 h.
Cholesterol efﬂux assay
Peritoneal macrophages from Prdx1C/C and prdx1¡/¡ mice
were incubated for 30 h in media containing 50 mg/mL of mod-
iﬁed lipoproteins (Alfa Aesar, J65591) that had been pre-incu-
bated with 5 mCi/mL3H-cholesterol (GE Healthcare Life
Sciences, TRK330). Cells were washed and equilibrated over-
night in 0.2% fetal bovine serum-containing DMEM medium,
and cholesterol efﬂux was determined in the presence or
absence of 50 mg/mL human recombinant APOA1/APOA-I
(Sigma Aldrich, A0722) or mouse serum (2%; Sigma Aldrich,
M5905) in FBS-free media with the indicated reagent (100 mM
paraoxon [Sigma Aldrich, 36186], or 30 mM chloroquine
[Sigma Aldrich, C6628]) for 24 h. Efﬂux is expressed as a per-
centage of 3H-cholesterol in the medium to 3H-cholesterol in
the mediumC3H-cholesterol in the cells.
Electron microscopy
After removal from the mice, aortas were ﬁxed with glutaralde-
hyde, then tissue from atherosclerotic regions of the aortic arch
was cut into blocks of 1 mm3 and post-ﬁxed with 1% osmium
tetroxide (Sigma Aldrich, 75632) in phosphate buffer (0.2 M,
pH 7.4) for 2 h. Samples were then dehydrated in a graded eth-
anol series and embedded in poly/Bed-812 resin (Polysciences,
08792–1). Semi-thin sections were stained with toluidine blue
and examined by light microscopy. Ultrathin sections were
stained with uranyl acetate and lead citrate and photographed
with a transmission electron microscope (HITACHI H-7650).
Atherosclerotic lesion analysis
For atherosclerotic lesion formation experiments, 8-wk-old
mice were fed a normal chow diet for 20 wk or a high-fat diet
(20% fat, 0.15% cholesterol; Research Diets, D12079B) for
10 weeks. Mice were fasted for 4 h and anesthetized with 0.6 ml
of 1.2% avertin (Sigma Aldrich, T48402) per 25 g body weight.
The hearts and aortas were then perfused with PBS through the
left ventricle. The hearts were embedded in OCT compound
(Sakura Finetek, 4583) and frozen on dry ice. The aortas were
dissected from the proximal ascending aorta to the bifurcation
of the iliac artery, and adventitial fat was removed. For en face
analysis, the aortas were split longitudinally, pinned onto ﬂat,
black silicone plates, and ﬁxed overnight in 10% formaldehyde
in PBS. Fixed aortas were stained with Oil Red O solution for
16 h, brieﬂy washed with PBS, and digitally photographed at a
ﬁxed magniﬁcation (Carl Zeiss, Jena, Germany, Axio Zoom.
V16). Total aortic areas and lesion areas were calculated using
the AxioVision program. For analyzing aortic sinus plaque
lesions, cryosectioning was performed. Each 10-mm-thick sec-
tion was stained with Oil Red O and Hematoxylin and Eosin
staining for quantiﬁcation of atherosclerosis, and the images
were photographed using an Axiovert 200 (Carl Zeiss, Jena,
Germany).
Bone marrow transplantation
The apoe¡/¡, prdx1¡/¡apoe¡/¡, GFPtg-LC3 apoe¡/¡, and GFPtg-
LC3 prdx1¡/¡apoe¡/¡ donor mice were killed using carbon
dioxide, and the femurs and tibia were dissected. Sterile PBS
was used to ﬂush the marrow from each bone, after which the
marrow was pooled. MACS LD columns (Miltenyi Biotec, 130–
042–901) conjugated with CD5 (Ly-1) MicroBeads (Miltenyi
Biotec, 130–049–301) were used to deplete mature T cells from
the BM. Four-wk-old apoe¡/¡ and prdx1¡/¡ apoe¡/¡ recipient
mice were lethally irradiated using gamma rays (2 £ 5 Gy, 4 h
apart). BM cells (1 £ 106) from donor mice suspended in
100 ml of sterile PBS were administered intravenously to each
irradiated mouse. After transplantation, the mice were fed a
normal chow diet for 4 wk, then a high-fat diet for 10 wk before
en face and aortic sinus assays.
Statistical analysis
All data displayed in the text and ﬁgures are expressed as mean
§ SEM. The n numbers are indicated for each experiment in
the ﬁgure legends. Comparison between 2 groups was analyzed
using the Mann-Whitney U test. Statistical signiﬁcance was
determined with P values < 0.05.
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